Key result
Mitral valve thickening documented at the time of acute rheumatic fever diagnosis is an independent predictor of chronic valve dysfunction (OR 5.8).
Why the study?
No definitive diagnostic test for ARF exists, and the role of Doppler echocardiography for long-term prognostic evaluation following ARF is not well established.
Does baseline mitral valve thickening on echocardiography predict chronic valve dysfunction in patients with acute rheumatic fever?
Cohort (n=70)
No
Does baseline mitral valve thickening on echocardiography predict chronic valve dysfunction in patients with acute rheumatic fever?
Answers are grounded in this paper and cite their sources.
Mitral valve thickening documented by echocardiography at the time of acute rheumatic fever diagnosis is a strong independent predictor of subsequent evolution to chronic rheumatic heart disease.
BACKGROUND: Rheumatic heart disease (RHD) complicating acute rheumatic fever (ARF) remains an important health problem in developing countries. No definitive diagnostic test for ARF exists and the role of Doppler echocardiography (DEC) for long-term prognostic evaluation following ARF is not well established. OBJECTIVE: To investigate the prognostic value of DEC in patients with ARF as a predictor of chronic valve dysfunction. METHODS: Prospectively enrolled patients with clinical ARF had a DEC performed soon after diagnosis and repeated at 1, 3, 6 and 12 months and thereafter at every 1-2 years. We defined chronic valve dysfunction by ≥ 3 of the following: increased valve thickening, commissure fusion, subvalvular thickening, reduced leaflet mobility, non-trivial mitral and/or aortic regurgitation. We performed univariate analysis and developed multivariate logistic regression models to identify variables that may influence evolution to RHD. p <0.05 was considered significant. RESULTS: We evaluated 70(57% men) patients, 10.8±5.6 years-old during the ARF episode and followed for 95±26 months. Chronic valve dysfunction was identified in 36(51.4%) which fulfilled criteria for RHD and 10(27.8%) of them died or underwent valve surgery. Univariate analysis showed that mitral valve thickening and presence of mitral regurgitation at baseline DEC, were associated with RHD(p<0.01). Multivariate logistic regression showed that only mitral valve thickness either as a continuous (Odds-Ratio:5.8;95%CI:1.7-19.7) or as a categorical variable (Odds-Ratio:4.04;95%CI:1.06-15.3) was an independent predictor of chronic valve dysfunction. CONCLUSIONS: Mitral leaflets thickening documented at the time of diagnosis of ARF is a consistent prognostic marker for the subsequent evolution to RHD.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2021) conducted a cohort in Acute rheumatic fever (n=70). Mitral valve thickening vs. Normal mitral valve thickness was evaluated on Chronic valve dysfunction (Rheumatic Heart Disease) (OR 5.8, 95% CI 1.7-19.7, p=<0.05). Mitral valve thickening documented at the time of acute rheumatic fever diagnosis is an independent predictor of chronic valve dysfunction (OR 5.8).
Synapse has enriched 10 related papers. Consider them for comparative context: